Gagnon Robert E. insider trades
Gagnon Robert E. has filed 38 Form 4s with the SEC that we hold, for Verastem, Inc. (VSTM) (Director), Opus Genetics, Inc. (IRD) (Chief Financial Officer), Bone Biologics Corp (BBLG) (Director) and Harvard Bioscience INC (HBIO) (Director). Across all of them we count 0 purchases worth $0 and 34 sales worth $578.8K reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($243.0K). The largest single trade was a sale of 28,000 shares of Opus Genetics, Inc. worth $127.2K, dated 2026-09-03. Of 2 sales filed since we began reading the 10b5-1 checkbox, 1 (50%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-12-17 and the latest 2026-10-27.
Verastem, Inc. (VSTM)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-12-20 | S, sale reported on Form 4 | 5,497 | $12.5K | 2021-12-22 | SEC |
| 2022-01-03 | S, sale reported on Form 4 | 19,612 | $40.2K | 2022-01-05 | SEC |
| 2022-03-21 | S, sale reported on Form 4 | 1,409 | $1.8K | 2022-03-23 | SEC |
| 2022-05-16 | S, sale reported on Form 4 | 16,627 | $17.1K | 2022-05-17 | SEC |
| 2022-06-21 | S, sale reported on Form 4 | 1,351 | $1.5K | 2022-06-22 | SEC |
| 2022-09-19 | S, sale reported on Form 4 | 1,348 | $1.5K | 2022-09-21 | SEC |
| 2022-12-16 | S, sale reported on Form 4 | 12,408 | $5.0K | 2022-12-20 | SEC |
| 2022-12-19 | S, sale reported on Form 4 | 1,429 | $529 | 2022-12-20 | SEC |
| 2023-03-16 | S, sale reported on Form 4 | 3,654 | $1.5K | 2023-03-20 | SEC |
| 2023-03-20 | S, sale reported on Form 4 | 1,664 | $716 | 2023-03-20 | SEC |
| 2023-06-16 | S, sale reported on Form 4 | 283 | $2.8K | 2023-06-21 | SEC |
| 2023-06-20 | S, sale reported on Form 4 | 130 | $1.3K | 2023-06-21 | SEC |
| 2023-09-18 | S, sale reported on Form 4 | 278 | $2.8K | 2023-09-20 | SEC |
| 2023-09-19 | S, sale reported on Form 4 | 130 | $1.3K | 2023-09-20 | SEC |
| 2023-12-18 | S, sale reported on Form 4 | 284 | $2.2K | 2023-12-20 | SEC |
| 2023-12-19 | S, sale reported on Form 4 | 130 | $1.0K | 2023-12-20 | SEC |
| 2024-01-12 | S, sale reported on Form 4 | 9,204 | $100.8K | 2024-01-17 | SEC |
| 2024-02-06 | S, sale reported on Form 4 | 9,204 | $126.1K | 2024-02-07 | SEC |
| 2024-03-18 | S, sale reported on Form 4 | 283 | $3.0K | 2024-03-20 | SEC |
| 2024-03-19 | S, sale reported on Form 4 | 130 | $1.3K | 2024-03-20 | SEC |
| 2024-06-17 | S, sale reported on Form 4 | 283 | $988 | 2024-06-20 | SEC |
| 2024-06-20 | S, sale reported on Form 4 | 131 | $421 | 2024-06-20 | SEC |
| 2024-09-16 | S, sale reported on Form 4 | 287 | $804 | 2024-09-18 | SEC |
| 2024-09-19 | S, sale reported on Form 4 | 131 | $365 | 2024-09-20 | SEC |
| 2024-12-16 | S, sale reported on Form 4 | 285 | $1.3K | 2024-12-20 | SEC |
| 2024-12-19 | S, sale reported on Form 4 | 130 | $568 | 2024-12-20 | SEC |
| 2025-03-17 | S, sale reported on Form 4 | 284 | $2.0K | 2025-03-19 | SEC |
| 2025-06-16 | S, sale reported on Form 4 | 284 | $1.6K | 2025-06-20 | SEC |
| 2025-09-16 | S, sale reported on Form 4 | 281 | $2.8K | 2025-09-18 | SEC |
| 2025-12-16 | S, sale reported on Form 4 | 283 | $2.6K | 2025-12-18 | SEC |
Opus Genetics, Inc. (IRD)
Bone Biologics Corp (BBLG)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Harvard Bioscience INC (HBIO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1504983) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
